Polyneuropathy Quality Measurement Set: Quality Improvement in Neurology

Abstract

Peripheral neuropathy affects ∼5% of the population and diabetes is the most common cause.1 Diabetic neuropathy often leads to pain, but clinicians do not always address neuropathic pain with their patients.1,2 Given the effect of painful diabetic neuropathy (PDN) on patients' quality of life, appropriate treatment of this prevalent condition is essential.1 To increase the delivery of effective management for patients with PDN, the American Academy of Neurology Institute (AANI) published a guideline on the treatment of PDN in 2011, and recently updated this guideline.1 © American Academy of Neurology.